Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Follicle Stimulating Hormone Market from 2024 to 2033?

In recent times, the market size of the follicle stimulating hormone (FSH) has seen robust growth. The projection is a rise from $1.94 billion in 2023 to $2.05 billion in 2024, marking a compound annual growth rate (CAGR) of 5.7%. This substantial increase can be linked to a higher occurrence of hormonal disorders, escalating demand for fertility treatments, proliferation of FSH indications, the introduction of new FSH products into the market, and increased demand for safe and reliable contraceptive methods.

The market size for follicle stimulating hormone is anticipated to undergo consistent augmentation in the coming years. The market is projected to expand to $2.49 billion by 2028, with a compound annual growth rate (CAGR) of 5.0%. The projected growth during the forecast timeframe can be credited to an increase in therapeutic applications, burgeoning demand for combination therapy, the escalating requirement for efficient contraceptive alternatives, an aging populace and associated healthcare needs, and market proliferation in pivotal regions. Some prevailing trends for the forecast period entail improved biosimilar fsh products, obtaining regulatory approvals and market accessibility, advancements in technology for fsh production and distribution, coupled with a surged demand for efficient contraceptive alternatives.

Claim Your Free Sample of the Global Follicle Stimulating Hormone Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12486&type=smp

What Key Factors Are Fueling the Growth of the follicle stimulating hormone Market?

The rise in infertility cases is anticipated to fuel expansion in the follicle-stimulating hormone market. Infertility, which affects the reproductive mechanism in both genders, is characterized by the failure to become pregnant despite a year or more of consistent, unprotected sexual intercourse. Follicle-stimulating hormones play a vital role in egg maturation in the ovaries and menstrual cycle regulation in females. Simultaneously, in males, they support testicular growth and assist in crafting a protein crucial to male fertility by fostering the growth of healthy sperm cells. For instance, the World Health Organization, a Switzerland-based United Nations special agency, stated in April 2023 that approximately 1 out of every 6 adults globally or 17.5% of the adult population suffered from infertility. Additionally, as per the Australian Bureau of Statistics, a self-governing constitutional organization in Australia tasked with data collection and analysis, there were 300,684 registered births in 2022, marking a 3% decrease from the previous year. The total fertility rate for all Australian women stood at 1.63 births per woman. Consequently, the escalating prevalence of infertility is spurring the follicle-stimulating hormone market’s growth.

What Are the Major Segments of the Follicle Stimulating Hormone Market?

1) By Type: Recombinant FSH, Urinary FSH

2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications

3) By End-Users: Infertility Center, Hospitals, Other End-Users

What New Trends Are Transforming the Follicle Stimulating Hormone Market?

One prominent trend emerging in the follicle-stimulating hormone market is the focus on product innovations. To enhance their market position, major enterprises operating in this sector are channeling their efforts towards the creation of state-of-the-art products. An example of this is the Pergoveris Pen, introduced in August 2021 by Merck Specialties Pvt. Ltd., a healthcare firm based in India. This groundbreaking tool is aimed at improving fertility treatment options within the country. The Pergoveris Pen is a unique device that merges recombinant follicle-stimulating hormone (FSH) and recombinant luteinizing hormone (LH) into an easy-to-use, pre-loaded format. Notably, it is the first product to incorporate these hormones in a pen injector. The Pergoveris Pen, tailored for use under the direction of IVF experts, provides an integrated treatment approach for women diagnosed with severe insufficiencies of follicle-stimulating hormone (FSH) and luteinizing hormone (LH).

Order Now for Fast Delivery of Your Follicle Stimulating Hormone Market Report!

https://www.thebusinessresearchcompany.com/report/follicle-stimulating-hormone-global-market-report

Which Regions Are Driving Growth in the Follicle Stimulating Hormone Market?

North America was the largest region in the follicle stimulating hormone market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the follicle stimulating hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Follicle Stimulating Hormone Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the follicle stimulating hormone market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Follicle Stimulating Hormone Market Include

1. Follicle Stimulating Hormone Market Executive Summary

2. Follicle Stimulating Hormone Market Segments

3. Follicle Stimulating Hormone Market Size And Template Market Growth Rate

4. Key Follicle Stimulating Hormone Market Trends

5. Major Follicle Stimulating Hormone Market Drivers

……

25. Key Mergers And Acquisitions In The Follicle Stimulating Hormone Market

26. Top Follicle Stimulating Hormone Companies

27. Follicle Stimulating Hormone Market Opportunities And Strategies

28. Follicle Stimulating Hormone Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Orthopedic Biomaterials Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/orthopedic-biomaterials-global-market-report

Biosimilar Hormones Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

Liquid Biopsy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: